Following the pioneering work by Alain Cribier1, Germany has been leading the clinical adoption of transcatheter aortic valve implantation (TAVI) in Europe2 and worldwide. Since 2008, all surgical aortic valve replacements (SAVR) and all TAVI procedures are registered within a nationwide quality assurance programme providing unique insights into the development of the treatment of aortic valve stenosis since the advent of TAVI. This short report updates our previous summary (2008-2014) of the annual quality reports until 20173.
Sign in to read and download the full articleForgot your password?
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com